Domains for activation and inactivation in G protein-coupled receptors - A mutational analysis of constitutive activity of the adenosine A2B receptor

被引:10
作者
Peeters, Miriam C. [1 ]
Li, Qilan [1 ]
Elands, Rachel [1 ]
van Westen, Gerard J. P. [1 ]
Lenselink, Eelke B. [1 ]
Mueller, Christa E. [2 ]
IJzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, NL-2300 RA Leiden, Netherlands
[2] Univ Bonn, Inst Pharmaceut, PSB, D-53121 Bonn, Germany
关键词
G protein-coupled receptor; Adenosine A(2B) receptor; Receptor activation mechanism; Constitutively inactive mutant (CIM); Saccharomyces cerevisiae; RANDOM MUTAGENESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; A(2A) RECEPTOR; GPCR; IDENTIFICATION; AGONIST; YEAST; MUTANTS; BINDING;
D O I
10.1016/j.bcp.2014.08.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) are a major drug target and can be activated by a range of stimuli, from photons to proteins. Most, if not all, GPCRs also display a basal level of biological response in the absence of such a stimulus. This level of so-called constitutive activity results from a delicate energy equilibrium that exists between the active and the inactive state of the receptor and is the first determinant in the GPCR activation mechanism. Here we describe new insights in specific regions of the adenosine A(2B) receptor that are essential in activation and inactivation. We developed a new screening method using the MMY24 S. Cerevisiae strain by which we were able to screen for constitutively inactive mutants receptors (CIMs). We applied this screening method on a mutagenic library of the adenosine A2B receptor, where random mutations were introduced in transmembrane domains four and five (TM4 and TM5) linked by extracellular loop 2 (EL2). The screen resulted in the identification of 22 single and double mutant receptors, all showing a decrease in constitutive activity as well as in agonist potency. By comparing these results with a previous screen of the same mutagenic library for constitutively active mutant receptors (CAMs), we discovered specific regions in this G protein-coupled receptor involved in either inactivation or activation or both. The results suggest the activation mechanism of GPCRs to be much less restricted to sites of high conservation or direct interaction with the ligand or G protein and illustrate how dynamic the activation process of GPCRs is. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:348 / 357
页数:10
相关论文
共 48 条
[1]   Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding [J].
Ahn, Kwang H. ;
Scott, Caitlin E. ;
Abrol, Ravinder ;
Goddard, William A., III ;
Kendall, Debra A. .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2013, 81 (08) :1304-1317
[2]   C5a receptor activation - Genetic identification of critical residues in four transmembrane helices [J].
Baranski, TJ ;
Herzmark, P ;
Lichtarge, O ;
Gerber, BO ;
Trueheart, J ;
Meng, EC ;
Iiri, T ;
Sheikh, SP ;
Bourne, HR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) :15757-15765
[3]   Techniques: How to boost GPCR mutagenesis studies using yeast [J].
Beukers, MW ;
Ijzerman, AP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (10) :533-539
[4]   Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast.: Identification of constitutively active and gain of function mutations [J].
Beukers, MW ;
van Oppenraaij, J ;
van der Hoorn, PPW ;
Blad, CC ;
den Dulk, H ;
Brouwer, J ;
IJzerman, AP .
MOLECULAR PHARMACOLOGY, 2004, 65 (03) :702-710
[5]   Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery [J].
Bond, RA ;
IJzerman, AP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (02) :92-96
[6]   1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity [J].
Borrmann, Thomas ;
Hinz, Sonja ;
Lertarelli, Daniela C. G. ;
Li, Wenjin ;
Florin, Nicole C. ;
Scheiff, Anja B. ;
Mueller, Christa E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) :3994-4006
[7]  
Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO
[8]  
2-K
[9]   A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation [J].
Canals, Meritxell ;
Lane, J. Robert ;
Wen, Adriel ;
Scammells, Peter J. ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (01) :650-659
[10]   Constitutively active G protein-coupled receptor mutants: Implications on receptor function and drug action [J].
Cotecchia, S ;
Fanelli, F ;
Costa, T .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (02) :311-316